Savara Pharmaceuticals develops inhaled pulmonary therapeutics—dry‑powder vancomycin AeroVanc for MRSA in cystic fibrosis, MOLBREEVI for autoimmune pulmonary alveolar proteinosis, and NanoCluster formulation technology.
Part of: Austin Hiring List